Physician profile
Perry Younger
NPI 1295709905
$3,001.97
in general payments reported to CMS, 2019-2025
20 companies · $983 in 2025
The $983 reported for 2025 was more than what 77% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $896 · 2020: $271 · 2021: $121 · 2022: $232 · 2023: $205 · 2024: $294 · 2025: $983.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,482.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,481.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $424.15 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $406.59 | 2024-2025 | Xiidra, Miebo, Vyzulta |
| Alcon Vision LLC | $384.09 | 2019-2024 | Hydrus Microstent, Centurion |
| Tarsus Pharmaceuticals, INC. | $356.88 | 2024-2025 | Xdemvy |
| Abbvie INC. | $324.14 | 2022-2025 | Xen Glaucoma Treatment System |
| Ivantis, INC | $232.80 | 2019-2021 | |
| Carl Zeiss Meditec, INC. | $210.91 | 2019 | |
| Biotissue Holdings INC. | $160.96 | 2025 | |
| Apellis Pharmaceuticals, INC. | $118.63 | 2022-2023 | |
| Johnson & Johnson Surgical Vision, INC. | $115.67 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $76.49 | 2019-2021 | |
| Coherus Oncology, INC. | $29.82 | 2023 | |
| Johnson & Johnson Vision Care, INC. | $27.68 | 2024 | |
| Glaukos Corporation | $25.96 | 2024 | Istent Trabecular Micro-Bypass System Model Is3 |
| Genentech USA, INC. | $21.97 | 2023 | Vabysmo |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $19.22 | 2025 | Tepezza |
| Astellas Pharma US INC | $19.20 | 2024 | Izervay |
| Horizon Therapeutics Plc | $16.60 | 2023 | Tepezza |
| Mallinckrodt Enterprises LLC | $16.38 | 2019 | |
| Sight Sciences, INC. | $13.83 | 2025 | Sion Surgical Instrument, Omni Surgical System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Perry Younger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.